Skip to main content
SpringerLink
Log in

Radiation Therapy for Prostate Cancer: The Role for Dose Escalation

  • Original Article
  • Published:
Comprehensive Therapy

Recent technological advances in radiation treatment delivery have allowed relatively higher doses of radiation to be delivered safely to the prostate. Emerging data suggest improvements in disease control with higher doses of radiation in subsets of patients with prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Puck TT, Marcus PI. Action of X-rays on mammalian cells. J Exp Med 1956;103:653–66.

    Article  PubMed  CAS  Google Scholar 

  2. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150(1):110–4.

    PubMed  CAS  Google Scholar 

  3. Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Macklis R, et al. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Cancer J Sci Am 1997;3(2):78–87.

    PubMed  CAS  Google Scholar 

  4. Blute ML, Bergstralh EJ, Partin AW, Walsh PC, Kattan MW, Scardino PT, et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol 2000;164(5):1591–5.

    Article  PubMed  CAS  Google Scholar 

  5. Kattan MW, Zelefsky MJ, Kupelian PA, Scardino PT, Fuks Z, Leibel SA. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 2000;18(19):3352–9.

    PubMed  CAS  Google Scholar 

  6. Kattan MW, Zelefsky MJ, Kupelian PA, Cho D, Scardino PT, Fuks Z, et al. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol 2003;21(24):4568–71.

    Article  PubMed  Google Scholar 

  7. D’Amico AV, Whittington R, Malkowicz SB, Weinstein M, Tomaszewski JE, Schultz D, et al. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol 2001;166(6):2185–8.

    Article  PubMed  CAS  Google Scholar 

  8. Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE, Venkatramen ES, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998;41(3):491–500.

    Article  PubMed  CAS  Google Scholar 

  9. Roach M, Lu J, Pilepich MV, Asbell SO, Mohuiddin M, Terry R, et al. Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials. Int J Radiat Oncol Biol Phys 2000;47(3):609–15.

    Article  PubMed  CAS  Google Scholar 

  10. Roach M, Weinberg V, McLaughlin PW, Grossfeld G, Sandler HM. Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate. Urology 2003;61(4):730–5.

    Article  PubMed  Google Scholar 

  11. Stephenson AJ, Shariat SF, Zelefsky MJ, et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004;291(11):1325–32.

    Article  PubMed  CAS  Google Scholar 

  12. Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC trial 22911). Lancet 2005;366(9485):572–8.

    Article  PubMed  Google Scholar 

  13. Valicenti RK, Gomella LG, Perez CA. Radiation therapy after radical prostatectomy: a review of the issues and Options. Sem Rad Onc 2003;13(2):130–40.

    Article  Google Scholar 

  14. Valicenti RK, Gomella LG, Ismail M, et al. Effect of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer. Int J Rad Onc Biol Phys 1998;42:501–6.

    Article  CAS  Google Scholar 

  15. Coen JJ, Zietman LL, Thakral H, Shipley WU. Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. J Clin Oncol 2002;20(15):3199–205.

    Article  PubMed  Google Scholar 

  16. Zelefsky MJ, Hunt MA, Fuks Z, Yamada Y, Chan HM, Ben Porat L, et al. Long-term distant metastases-free survival and cause-specific survival outcomes after high dose conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2006;66(3):S9.

    Google Scholar 

  17. Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. Increasing radiotherapy dose for prostate cancer reduces a late wave of distant metastasis. Int J Rad Onc Biol Phys 2006;66(3):S9–10.

    Google Scholar 

  18. Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys 2002;54(3):677–85.

    Article  PubMed  Google Scholar 

  19. Kuban D, Tucker S, Dong L, Huang E, Lee A, Cheung R, et al. Long-term results of a randomized dose escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2006;66(3):S8–9.

    Google Scholar 

  20. Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Schultheiss TE. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am 1999;5(3):152–8.

    PubMed  CAS  Google Scholar 

  21. Kupelian PA, Buchsbaum JC, Patel C, Elshaikh M, Reddy CA, Zippe C, et al. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Int J Radiat Oncol Biol Phys 2002;52(3):704–11.

    Article  PubMed  CAS  Google Scholar 

  22. Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 2006;176:1415–9.

    Article  PubMed  Google Scholar 

  23. Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995;32(1):3–12.

    Article  PubMed  CAS  Google Scholar 

  24. Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294(10):1233–9.

    Article  PubMed  CAS  Google Scholar 

  25. Hanks GE, Pajak TF, Porter A. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 2003;21:3972–8.

    Article  PubMed  CAS  Google Scholar 

  26. Roach M, DeSilvio M, Lawton C. Phase III trial comparing whole-pelvis versus protate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Oncology Group 9413. J Clin Oncol 2003;21:1904–11.

    Article  PubMed  Google Scholar 

  27. Bolla M, Collette L, Blank L. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): phase III randomized trial. Lancet 2005;366:572–8.

    Article  PubMed  Google Scholar 

  28. Dearnaley DP, Hall E, Lawrence D, Huddart RA, Eeles R, Nutting CM, et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 2005;92:488–98.

    Article  PubMed  CAS  Google Scholar 

  29. Zapatero A, Valcarcel F, Calvo FA, Algas R, Bejar A, Maldonado J, et al. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study. J Clin Oncol 2005;23:6561–8.

    Article  PubMed  Google Scholar 

  30. Stock RG, Cahlon O, Cesaretti JA, Kollmeier MA, Stone NN. Combined modality treatment in the management of high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2004;1352–9.

  31. Sylvester JE, Blasko JC, Grimm PD, Meier R, Malmgren JA. Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience. Int J Radiat Oncol Biol Phys 2003;57:944–52.

    Article  PubMed  Google Scholar 

  32. Dattoli M, Wallner K, True L, Cash J, Sorace R. Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma. Cancer 2003;97:979–83.

    Article  PubMed  Google Scholar 

  33. Brandeis JM, Litwin MS, Burnison CM, Reiter RE. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 2000;163:851–7.

    Article  PubMed  CAS  Google Scholar 

  34. Martinez A, Gonzalez J, Spencer W, Gustafson G, Kestin L, Kearney D, et al. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urol 2003;169:974–80.

    Article  PubMed  Google Scholar 

  35. Sathya, JR, Davis IR, Julian JA, Guo Q, Daya D, Dayes IS, et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 2005;23:1192–9.

    Article  PubMed  Google Scholar 

  36. Fowler J, Chappell R, Ritter M. Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 2001;50:1021–31.

    Article  PubMed  CAS  Google Scholar 

  37. Duchesne GM, Peters LJ. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1999;44:747–8.

    Article  PubMed  CAS  Google Scholar 

  38. Kupelian PA, Thakkar VV, Khuntia D, Reddy CA, Klein EA, Mahadevan A. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys 2005;63(5):1463–8.

    Article  PubMed  Google Scholar 

  39. Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys 2006;64(2):518–26.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Michael J. Swartz, Kristin Janson, Theodore L. DeWeese & Danny Y. Song

Authors
  1. Michael J. Swartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristin Janson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Theodore L. DeWeese
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Danny Y. Song
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Danny Y. Song.

About this article

Cite this article

Swartz, M.J., Janson, K., DeWeese, T.L. et al. Radiation Therapy for Prostate Cancer: The Role for Dose Escalation. Compr Ther 33, 216–222 (2007). https://doi.org/10.1007/s12019-007-8014-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12019-007-8014-7

Keywords

Search

Navigation